PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ((3-(sec-butyl)-4-(decyloxy)phenyl)methanetriyl)tribenzene | 801-941-7 | 1404190-37-9 | - | - | 2 | - | 1 | - | - | - | - | Details |
|
((4-phenylbutyl)hydroxyphosphoryl)acetic acid
SQ 26999
|
412-170-7 | 83623-61-4 | - | - | - | - | 1 | - | - | - | - | Details |
| ((Perfluorobutyl)ethyl)trimethoxysilane | 468-970-1 | 85877-79-8 | - | - | 1 | - | - | - | - | - | - | Details |
| (+)-bornan-2-one | 207-355-2 | 464-49-3 | - | - | - | - | 1 | - | - | - | - | Details |
| (+)-L-arginine hydrochloride | 214-275-1 | 1119-34-2 | - | - | - | - | 1 | - | - | - | - | Details |
| (+)-menthol | 239-387-8 | 15356-60-2 | - | - | - | - | 1 | - | - | - | - | Details |
| (+)-N-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutyramide | 211-569-1 | 667-83-4 | - | - | - | - | 1 | - | - | - | - | Details |
| (+)-neomenthol | 218-691-4 | 2216-52-6 | - | - | - | - | 1 | - | - | - | - | Details |
| (+)-tartaric acid | 201-766-0 | 87-69-4 | - | - | 6 | - | - | - | - | - | - | Details |
| (+-)-(3aRS,5aSR,9aSR,9bSR)-3a,6,6,9a-Tetramethyldodecahydronaphtho[2,1-b]furan | 948-069-4 | - | - | - | 1 | - | 1 | - | - | - | - | Details |